AMED
Amedisys
AMED
AMED
Delisted
AMED was delisted on the 14th of August, 2025.
286 hedge funds and large institutions have $3.07B invested in Amedisys in 2022 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 106 increasing their positions, 108 reducing their positions, and 71 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
46% less first-time investments, than exits
New positions opened: 38 | Existing positions closed: 71
48% less call options, than puts
Call options by funds: $18.4M | Put options by funds: $35.3M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
286
Holding in Top 10
1
Calls
$18.4M
Puts
$35.3M
Top Buyers
| 1 | +$59.2M | |
| 2 | +$37.6M | |
| 3 | +$31.7M | |
| 4 |
DM
Deerfield Management
New York
|
+$20.9M |
| 5 |
Morgan Stanley
New York
|
+$16M |
Top Sellers
| 1 | -$124M | |
| 2 | -$41.2M | |
| 3 | -$39.8M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$36M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$28.2M |